Rabu, 22 Januari 2025 (14:29)
Rabu, 22 Januari 2025 (14:29)
 Music |
 Video |
 Movies |
 Chart |
 Show |
 | Results from the APHINITY trial of two HER2 targeted agents with chemo (ecancer) View |
 | APHINITY Trial: Adjuvant HER2-Targeted Therapy in HER2+ BC (OncLive) View |
 | 3-year DFS in randomized trials of chemotherapy and HER2-targeted therapy (VJOncology) View |
 | The APHINITY Trial Regimen Efficacy u0026 Toxicity Profile (Targeted Oncology) View |
 | APHINITY Trial for HER2+ Breast Cancer (Targeted Oncology) View |
 | Breast Cancer: Dual HER2-Targeted Adjuvant Therapy (OncLive) View |
 | APHINITY Trial: Adjuvant Pertuzumab and Trastuzumab (Targeted Oncology) View |
